# reload+after+2024-01-23 19:47:08.320478
address1§1 Evertrust Plaza
address2§13th Floor
city§Jersey City
state§NJ
zip§07302-6548
country§United States
phone§201 884 5485
website§https://www.scynexis.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§SCYNEXIS, Inc., a biotechnology company, develops products for the treatment of fungal infections in the United States. It offers BREXAFEMME for the treatment of vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, an intravenous drug for the treatment of various fungal infections, including invasive candidiasis, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
fullTimeEmployees§36
companyOfficers§[{'maxAge': 1, 'name': 'Mr. David Gonzalez Angulo M.D.', 'age': 58, 'title': 'CEO, President & Director', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 631688, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Scott  Sukenick J.D.', 'age': 45, 'title': 'Chief Legal Officer & Corporate Secretary', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 542054, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ivor  Macleod CPA, M.B.A.', 'age': 62, 'title': 'Chief Financial Officer', 'yearBorn': 1961, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Debbie  Etchison', 'title': 'Executive Director of Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Daniella  Gigante', 'title': 'Vice President of Human Resources & Information Technology', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§2.079
priceToSalesTrailing12Months§0.51758134
currency§USD
dateShortInterest§1702598400
forwardEps§0.25
exchange§NGM
quoteType§EQUITY
shortName§SCYNEXIS, Inc.
longName§SCYNEXIS, Inc.
firstTradeDateEpochUtc§1399037400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§da0aad24-4d6f-3259-b774-240e8ba92427
gmtOffSetMilliseconds§-18000000
targetHighPrice§30.0
targetLowPrice§7.0
targetMeanPrice§12.5
targetMedianPrice§8.0
recommendationMean§1.6
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§6.669
grossMargins§0.99164003
ebitdaMargins§0.54361
trailingPegRatio§None
